Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 5997
Selected: 0
NCT IDTitle
NCT00150280Compare Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological Surgery
NCT01321437Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
NCT01299480A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years
NCT00327470An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD
NCT06467370A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults.
NCT035135882-Week Study In People With Nonalcoholic Fatty Liver Disease
NCT02260466Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.
NCT01183715A Single Dose Study Of PF-05161704 In Healthy Volunteers
NCT01251835Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan
NCT00322517Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer
NCT00728624Assessing Prevalence Of Beta Lactamase Production From Clinical Isolates Of Hospitalized Patients And Comparison Of Antibiotic Susceptibility Patterns
NCT02391623A Multiple Oral Doses Study Of PF-06427878 In Healthy Adult Subjects
NCT05069259Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.
NCT01558661Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
NCT01520870Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.
NCT00708682Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in Mexico
NCT01707082A Study To Test The Safety, Amount And Effects Of PF-06282999 In Healthy Overweight Adults And A Study To Test The Effects Of PF-06282999 On The Amount Of The Approved Drug, Midazolam, In Healthy Adults
NCT00242229Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder
NCT00784420Drug Interaction Study Between Raltegravir And UK-453,061
NCT00582660Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib
NCT00555373Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression
NCT01490866A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)
NCT00745186Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers
NCT05660356Growth Hormone Deficiency in Mild Traumatic Brain Injury
NCT03573882Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031
NCT06122194A Study to Learn PF-07817883 Blood Levels After Administration of Tablets of Study Drug to Healthy Adult Volunteers
NCT04471493Pediatric and Ambulatory Research in Infectious Diseases
NCT00495625Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)
NCT04863417Study to Evaluate the Safety, Local and Systemic Tolerability, and Pharmacokinetics of Multiple-Dose Topical Administration of PF-07038124 in Japanese Healthy Participants
NCT02226172Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib
NCT02689167Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma
NCT00523432A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies
NCT04389632A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT01173757To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers
NCT00952198A Safety Study of ARRY-403 in Patients With Type 2 Diabetes
NCT01155063Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients
NCT03969121Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
NCT00840801Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children
NCT01101932Multiple Dose Escalation Trial Of PF-04308515 In Healthy Volunteers
NCT00264693Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function
NCT06712836A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight
NCT06634836Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B
NCT03643211Xeljanz Special Investigation for Long-term Use in UC Patients
NCT05554237A Study to Learn About the Study Medicine Called CTB+AVP in Healthy Adult People.
NCT00479557Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
NCT00795639Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)
NCT03992781Changes of Depression After First-year of Tofacitinib in RA Patients
NCT05509400Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use
NCT01209598PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma
NCT00862667A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers.